Study Demonstrates Accuracy of Two Quest Blood Tests for Alzheimer’s Diagnosis
Two biomarker panels demonstrated 91% sensitivity and specificity in symptomatic patients, potentially reducing the need for PET imaging confirmation.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
AI-Enhanced EEG Promises Early Alzheimer’s Detection
AI-enhanced EEG technology is emerging as a promising tool for early detection of Alzheimer's disease, potentially facilitating prevention efforts before symptoms appear.
Dementias & Alzheimer’s
Latest
Blood Test for Alzheimer’s Cleared by FDA
An FDA-cleared blood test that measures key Alzheimer’s disease biomarkers is a less invasive, more accurate method to diagnose the condition.
pTau217 Antibody Demonstrates High Rate of Reliability and Scalability
ALZpath, Inc. announced that it presented data from evaluations of its proprietary pTau217 antibody for blood-based Alzheimer’s diagnostics.
Read More
Alzheimer’s Disease Diagnosed with Highly Accurate Blood Test
A new blood test for Alzheimer’s disease not only aids in diagnosis but also helps determine the disease’s progression.
Read More
Video Game Test May Be as Effective as Blood Tests for Alzheimer’s Early Detection
A video game test may help detect Alzheimer’s years before symptoms appear, offering a non-invasive alternative to blood tests.
Read More
IL-12 Is the Messenger Fueling Alzheimer’s
Microglia can transition from protective to harmful with age, producing inflammatory messengers like IL-12, which accelerates Alzheimer’s.
Read More
Blood Test May Be Means for Early Detection of Dementia
A blood test originally developed for Alzheimer’s can help predict dementia in patients with iRBD years before symptoms appear.
Read More
P-tau not as Disease-Specific for Alzheimer’s as Previously Thought
The detection of p-tau proteins in the blood for early Alzheimer’s disease (AD) diagnosis is less specific than previously believed.
Read More
Study Aims to Identify New Auditory Biomarkers
The SAPHIR study aims to develop auditory biomarkers for early detection and improved disease management related to cognitive decline.
Read More
Biomarker Test Can Detect Alzheimer’s Earlier
A biomarker test can detect early-stage tau protein clumping associated with Alzheimer’s disease up to a decade before tau tangles appear.
Read More
Unifying Model of Alzheimer’s Disease Proposed
Scientists have proposed a unifying explanation for Alzheimer’s disease, linking widespread gene disruption to chronic stress granules.
Read More
Mouth Bacteria May Give Window into Future Brain Function
Research suggests that mouth bacteria may influence memory and cognitive function, some promoting brain health while others risk Alzheimer’s.
Read More
Neurocode Study Compares Alzheimer’s Assays
Neurocode USA Inc. published a study showing that its ALZpath pTau217 assay outperforms the Fujirebio assay in detecting Alzheimer’s disease.
Read More
Alzheimer’s Disease Blood Biomarker Test Improves Clinical Decision-Making
The use of the PrecivityAD2 blood biomarker test significantly improved clinicians’ confidence in diagnosing Alzheimer’s disease.
Read More
FDA Grants Breakthrough Device Designation for Beckman Coulter Alzheimer’s Blood Test
The FDA granted Breakthrough Device Designation to Beckman Coulter’s Access p-Tau217/β-Amyloid 1-42 plasma ratio blood test.
Read More
New Biomarker Tests Enable Early Diagnosis of Synucleinopathies
A new expert-led paper highlights the potential of biomarker testing to improve early diagnosis and treatment of synucleinopathies.
Read More
New Guidelines Developed to Diagnose Common Memory Disorder Mistaken for Alzheimer’s
New guidelines for limbic-predominant age-related TDP-43 encephalopathy aim to differentiate the memory-loss syndrome from Alzheimer’s.
Read More